ACCD(Delisted)
Accolade·NASDAQ
--
--(--)
Signals Analysis
Bullish signal 0
Bearish signal 1
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About ACCD
Accolade, Inc.
A company that provides personalized health and benefits solutions for people to improve their health care system
1201 Third Avenue, Suite 1700, Seattle, WA 98101
--
Accolade, Inc., was incorporated under the laws of the State of Delaware on January 23, 2007. The company provides personalized, technology-based solutions that help people better understand and leverage the benefits of the healthcare system and its workplace.
Company Financials
EPS
ACCD has released its 2025 Q3 earnings. EPS was reported at -1.5, versus the expected -0.16, missing expectations. The chart below visualizes how ACCD has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
ACCD has released its 2025 Q3 earnings report, with revenue of 105.06M, reflecting a YoY change of 5.73%, and net profit of -121.26M, showing a YoY change of -475.69%. The Sankey diagram below clearly presents ACCD's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
